Summary & Overview
CPT 90744: Pediatric/Adolescent Hepatitis B Vaccine, IM
CPT code 90744 denotes a pediatric/adolescent–dosage hepatitis B vaccine given intramuscularly as part of a three-dose immunization series. This code captures routine childhood and adolescent preventive care against hepatitis B, a nationally recommended vaccine that helps reduce transmission and long-term liver disease. Billing clarity for 90744 affects public and private payers, immunization program reporting, and preventive care delivery across outpatient settings.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the vaccine product, typical service settings, and the common payer landscape influencing coverage and claims processing. The publication summarizes benchmark considerations relevant to vaccination coding, common modifier usage patterns, and administrative points that impact reimbursement and claim adjudication.
The content is intended for billing managers, practice administrators, and policy analysts seeking a practical reference on CPT code 90744, including where it is used, why it matters for preventive care delivery, and what components are typically reviewed during claims and coverage assessments. Data not available in the input will be noted where applicable.
Billing Code Overview
CPT code 90744 represents a pediatric/adolescent–dosage hepatitis B vaccine administered intramuscularly. The vaccine is intended to protect against hepatitis B and is delivered as a three–dose schedule.
Service Type: Immunization/Vaccine administration
Typical Site of Service: Outpatient clinic, pediatrician's office, community health center, or public health clinic
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 2-month-old infant presents to a pediatric primary care clinic for routine immunizations per the recommended schedule. The patient is scheduled to receive the second dose of a pediatric/adolescent–dosage hepatitis B vaccine administered intramuscularly as part of the three-dose series. The clinical workflow includes verification of identity and immunization history, screening for contraindications (e.g., severe allergic reaction to prior dose or vaccine component), obtaining informed consent from the parent or guardian, preparation of the vaccine dose and appropriate syringe, administration of the vaccine intramuscularly (typically in the anterolateral thigh for infants), documentation of lot number, manufacturer, site, and route in the medical record and immunization registry, and scheduling the next dose. Typical site of service is an outpatient pediatric clinic, family medicine clinic, or community health center. The patient scenario may also occur during a well-child visit, walk-in immunization clinic, or school-based vaccination program for adolescents completing the three-dose schedule.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure | Use when a documented E/M visit is performed on the same day as vaccine administration for a separate problem. |